|
2015 Journal Article New pharmacological approaches for cystic fibrosis: Promises, progress, pitfallsBell, S.C., De Boeck, K. and Amaral, M.D. (2015). New pharmacological approaches for cystic fibrosis: Promises, progress, pitfalls. Pharmacology and Therapeutics, 145, 19-34. doi: 10.1016/j.pharmthera.2014.06.005 |
|
2015 Journal Article A phase 3, open-label, randomized trial to evaluate the safety and efficacy of levofloxacin inhalation solution (APT-1026) versus tobramycin inhalation solution in stable cystic fibrosis patientsStuart Elborn, J., Geller, David E., Conrad, Douglas, Aaron, Shawn D., Smyth, Alan R., Fischer, Rainald, Kerem, Eitan, Bell, Scott C., Loutit, Jeffery S., Dudley, Michael N., Morgan, Elizabeth E., VanDevanter, Donald R. and Flume, Patrick A. (2015). A phase 3, open-label, randomized trial to evaluate the safety and efficacy of levofloxacin inhalation solution (APT-1026) versus tobramycin inhalation solution in stable cystic fibrosis patients. Journal of Cystic Fibrosis, 14 (4), 507-514. doi: 10.1016/j.jcf.2014.12.013 |
|
2014 Journal Article JCF - 2014 and beyondBell, Scott C., Heijerman, Harry and Hartl, Dominik (2014). JCF - 2014 and beyond. Journal of Cystic Fibrosis, 13 (6), 610-611. doi: 10.1016/j.jcf.2014.09.009 |
|
2014 Journal Article Reduced mucosal associated invariant T-cells are associated with increased disease severity and Pseudomonas aeruginosa infection in cystic fibrosisSmith, Daniel J., Hill, Geoffrey R., Bell, Scott C. and Reid, David W. (2014). Reduced mucosal associated invariant T-cells are associated with increased disease severity and Pseudomonas aeruginosa infection in cystic fibrosis. PLoS ONE, 9 (10) e109891, 1-8. doi: 10.1371/journal.pone.0109891 |
|
2014 Journal Article Antimicrobial treatment of non-cystic fibrosis bronchiectasisGrimwood, K., Bell, S.C. and Chang, A.B. (2014). Antimicrobial treatment of non-cystic fibrosis bronchiectasis. Expert Review of Anti-Infective Therapy, 12 (10), 1277-1296. doi: 10.1586/14787210.2014.952282 |
|
2014 Journal Article Pyrosequencing reveals transient cystic fibrosis lung microbiome changes with intravenous antibioticsSmith, Daniel J., Badrick, Alison C., Zakrzewski, Martha, Krause, Lutz, Bell, Scott C., Anderson, Gregory J. and Reid, David W. (2014). Pyrosequencing reveals transient cystic fibrosis lung microbiome changes with intravenous antibiotics. European Respiratory Journal, 44 (4), 922-930. doi: 10.1183/09031936.00203013 |
|
2014 Journal Article Viability of Pseudomonas aeruginosa in cough aerosols generated by persons with cystic fibrosisKnibbs, Luke D., Johnson, Graham R., Kidd, Timothy J., Cheney, Joyce, Grimwood, Keith, Kattenbelt, Jacqueline A., O'Rourke, Peter K., Ramsay, Kay A., Sly, Peter D., Wainwright, Claire E., Wood, Michelle E., Morawska, Lidia and Bell, Scott C. (2014). Viability of Pseudomonas aeruginosa in cough aerosols generated by persons with cystic fibrosis. Thorax, 69 (8), 740-745. doi: 10.1136/thoraxjnl-2014-205213 |
|
2014 Journal Article A comparison of two informative SNP-based strategies for typing Pseudomonas aeruginosa isolates from patients with cystic fibrosisSyrmis, Melanie W., Kidd, Timothy J., Moser, Ralf J., Ramsay, Kay A., Gibson, Kristen M., Anuj, Snehal, Bell, Scott C., Wainwright, Claire E., Grimwood, Keith, Nissen, Michael, Sloots, Theo P. and Whiley, David M. (2014). A comparison of two informative SNP-based strategies for typing Pseudomonas aeruginosa isolates from patients with cystic fibrosis. BMC Infectious Diseases, 14 (1) 307, 307.1-307.8. doi: 10.1186/1471-2334-14-307 |
|
2014 Journal Article European Cystic Fibrosis Society standards of care: best practice guidelinesSmyth, A.R., Bell, S.C., Bojcin, S., Bryon, M., Duff, A., Flume, P., Kashirskaya, N., Munck, A., Ratjen, F., Schwarzenberg, S.J., Sermet-Gaudelus, I., Southern, K.W., Taccetti, G., Ullrich, G. and Wolfe, S. (2014). European Cystic Fibrosis Society standards of care: best practice guidelines. Journal of Cystic Fibrosis, 13 (S1), S23-S42. doi: 10.1016/j.jcf.2014.03.010 |
|
2014 Journal Article Elevated metal concentrations in the CF airway correlate with cellular injury and disease severitySmith, Daniel J., Anderson, Gregory J., Bell, Scott C. and Reid, David W. (2014). Elevated metal concentrations in the CF airway correlate with cellular injury and disease severity. Journal of Cystic Fibrosis, 13 (3), 289-295. doi: 10.1016/j.jcf.2013.12.001 |
|
2014 Journal Article Molecular imprint of exposure to naturally occurring genetic variants of human cytomegalovirus on the T cell repertoireSmith, Corey, Gras, Stephanie, Brennan, Rebekah M., Bird, Nicola L., Valkenburg, Sophie A., Twist, Kelly-Anne, Burrows, Jacqueline M., Miles, John J., Chambers, Daniel, Bell, Scott, Campbell, Scott, Kedzierska, Katherine, Burrows, Scott R., Rossjohn, Jamie and Khanna, Rajiv (2014). Molecular imprint of exposure to naturally occurring genetic variants of human cytomegalovirus on the T cell repertoire. Scientific Reports, 4 (1) 3993, 3993.1-3993.10. doi: 10.1038/srep03993 |
|
2014 Journal Article Pregnancy and cystic fibrosis: approach to contemporary managementGeake, James, Tay, George, Callaway, Leonie and Bell, Scott C. (2014). Pregnancy and cystic fibrosis: approach to contemporary management. Obstetric Medicine, 7 (4), 147-155. doi: 10.1177/1753495X14554022 |
|
2014 Journal Article A CFTR corrector (lumacaftor) and a CFTR potentiator (ivacaftor) for treatment of patients with cystic fibrosis who have a phe508del CFTR mutation: A phase 2 randomised controlled trialBoyle, Michael P., Bell, Scott C., Konstan, Michael W., McColley, Susanna A., Rowe, Steven M., Rietschel, Ernst, Huang, Xiaohong, Waltz, David, Patel, Naimish R. and Rodman, David (2014). A CFTR corrector (lumacaftor) and a CFTR potentiator (ivacaftor) for treatment of patients with cystic fibrosis who have a phe508del CFTR mutation: A phase 2 randomised controlled trial. The Lancet Respiratory Medicine, 2 (7), 527-538. doi: 10.1016/S2213-2600(14)70132-8 |
|
2014 Journal Article Challenges of providing care to adults with cystic fibrosisBell, Scott C. and Reid, David W. (2014). Challenges of providing care to adults with cystic fibrosis. European Respiratory Monograph, 64 (64), 286-303. doi: 10.1183/1025448x.10010513 |
|
2013 Journal Article Change in the executive editorial team at JCFBell, Scott, Hartl, Dominik and Heijerman, Harry (2013). Change in the executive editorial team at JCF. Journal of Cystic Fibrosis, 12 (6), 545-546. doi: 10.1016/j.jcf.2013.10.006 |
|
2013 Journal Article Ivacaftor in severe cystic fibrosis lung disease and a G551D mutationWood, Michelle E., Smith, Daniel J., Reid, David W., Masel, Philip J., France, Megan W. and Bell, Scott C. (2013). Ivacaftor in severe cystic fibrosis lung disease and a G551D mutation. Respirology Case Reports, 1 (2), 52-54. doi: 10.1002/rcr2.27 |
|
2013 Journal Article Factors influencing acquisition of Burkholderia cepacia complex organisms in patients with cystic fibrosisRamsay, Kay A., Butler, Claire A., Paynter, Stuart, Ware, Robert S., Kidd, Timothy J., Wainwright, Claire E. and Bell, Scott C. (2013). Factors influencing acquisition of Burkholderia cepacia complex organisms in patients with cystic fibrosis. Journal of Clinical Microbiology, 51 (12), 3975-3980. doi: 10.1128/JCM.01360-13 |
|
2013 Journal Article Within-host evolution of Burkholderia pseudomallei over a twelve-year chronic carriage infectionPrice E.P., Sarovich D.S., Mayo M., Tuanyok A., Drees K.P., Kaestli M., Beckstrom-Sternberg S.M., Babic-Sternberg J.S., Kidd T.J., Bell S.C., Keim P., Pearson T. and Currie B.J. (2013). Within-host evolution of Burkholderia pseudomallei over a twelve-year chronic carriage infection. mBio, 4 (4) e00388-13, e00388-13.1-e00388-13.11. doi: 10.1128/mBio.00388-13 |
|
2013 Journal Article ICU outcomes in cystic fibrosis following invasive ventilationReid, David W. and Bell, Scott C. (2013). ICU outcomes in cystic fibrosis following invasive ventilation. Respirology, 18 (4), 585-586. doi: 10.1111/resp.12077 |
|
2013 Journal Article High-throughput single-nucleotide polymorphism-based typing of shared Pseudomonas aeruginosa strains in cystic fibrosis patients using the Sequenom iPLEX platformSyrmis, Melanie W., Moser, Ralf J., Kidd, Timothy J., Hunt, Priscilla, Ramsay, Kay A., Bell, Scott C., Wainwright, Claire E., Grimwood, Keith, Nissen, Michael D., Sloots, Theo P. and Whiley, David M. (2013). High-throughput single-nucleotide polymorphism-based typing of shared Pseudomonas aeruginosa strains in cystic fibrosis patients using the Sequenom iPLEX platform. Journal of Medical Microbiology, 62 (5), 734-740. doi: 10.1099/jmm.0.055905-0 |
